Unlock Saliva’s Potential in Immune Monitoring

Ultra-sensitive Simoa® technology makes noninvasive, scalable, and high-fidelity immune profiling a reality.

Immune monitoring has long depended on venous blood draws—accurate but limited by infrastructure, cost, and patient burden. Now, saliva is emerging as a scientifically validated alternative, carrying both systemic (IgG) and mucosal (IgA) immune markers. Paired with the unmatched sensitivity of Quanterix’s Simoa® platform, saliva becomes more than a convenient matrix, it becomes a powerful tool for precision research.

In this application note, you’ll discover:

  • How saliva-based assays deliver sub-picogram sensitivity without complex sample preparation.
  • Data demonstrating saliva’s strong correlation with serum in vaccine response monitoring.
  • Why saliva enables repeat, decentralized, and population-scale immune studies.
  • Key applications across vaccine R&D, public health surveillance, pediatrics, geriatrics, and decentralized clinical trials.

Validated in peer-reviewed studies, saliva-based Simoa® assays open new possibilities for scalable, noninvasive immune monitoring, without sacrificing rigor, reproducibility, or analytical depth.

Fill out the form to download your copy of the application note and explore how saliva and Simoa® are redefining the future of immune monitoring.

By submitting the form you agree to Quanterix’s Terms and Conditions. If you have subscribed to our email marketing you can unsubscribe at any time, and you can learn more about how we manage your personal details in our Privacy Policy.

You might also like

APP NOTE

Expanding Access to Ultra-Sensitive Biomarker Testing: Urine as a Non-Invasive Matrix for Simoa Assays

PUBLICATION BRIEF

Beyond Blood: Expanding Simoa Applications in Urine, Saliva, Sweat, & Tears

WEBINAR

Decoding Alzheimer’s: The History, Biomarkers, and Clinical Advances